Injectable depot formulations and methods for providing sustained release of nanoparticle compositions

Details for Australian Patent Application No. 2006233345 (hide)

Owner Pfizer Products Inc.

Inventors Shah, Parang Suresh; Wagner, Dawn Renee; Wisniecki, Peter; Shah, Jaymin Chandrakant

Agent Spruson & Ferguson

Pub. Number AU-A-2006233345

PCT Pub. Number WO2006/109183

Priority 60/671,124 13.04.05 US

Filing date 10 April 2006

Wipo publication date 19 October 2006

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/109183 Priority application(s): WO2006/109183

27 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006233353-Human anti-interferon gamma antibodies and methods of use thereof

2006233333-Precipitated calcium carbonate pigment, especially for use in inkjet printing paper coatings